AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Threshold Pharmaceuticals Reports Fourth Quarter and Year End 2005 Financial Results and Provides 2006 Guidance.
Company to Host Conference Call at 4:30 p.m. ET Today
REDWOOD CITY, Calif., March 1 /PRNewswire-FirstCall/ -- Threshold Pharmaceuticals, Inc. , today reported financial results for the fourth quarter and the year ended December 31, 2005.
The net loss for 2005 was $44.4 million compared to a net loss of $23.6 million in 2004. Total research and development expenses for 2005 increased to $36.0 million from $16.3 million in 2004, as clinical trials for the Company's product candidates progressed, and staffing increased to support clinical development activities. General and administrative expenses were $11.2 million for 2005 versus $7.6 million in 2004. ...
- Phase Forward Reports Fourth Quarter and Full Year 2007 Results.(Financial...
- Press release article from: Business Wire January 31, 2008 700+ words
...over prior year * Fourth Quarter Non-GAAP operating...WALTHAM, Mass. -- Phase Forward Incorporated...representing 72.4% of fourth quarter total revenues...remarked, "The fourth quarter was a strong finish...successful year for Phase Forward. During...
- Phase Forward Reports Fourth Quarter and Full Year 2008 Results.(Financial...
- Press release article from: Business Wire February 5, 2009 700+ words
...at the end of the fourth quarter, an increase of...increase in cash in the fourth quarter was due primarily...prior quarter. Fourth Quarter Business Highlights * Phase Forward signed InForm...all clinical trial phases from Phase I through...
- Phase Forward Reports Record Fourth Quarter and Full Year 2006...
- Press release article from: Business Wire February 1, 2007 700+ words
...30.2 Million * Fourth Quarter Non-GAAP Income...4.1 Million Phase Forward Incorporated...remarked, "The fourth quarter was a strong finish...excellent year for Phase Forward. During...company purchased Phase Forward's WebVDME...products during the fourth quarter. ...
- A.P. Pharma Reports 2004 Fourth Quarter and Full Year Results; IND Submitted...
- Press release article from: Business Wire March 10, 2005 700+ words
...FDA to initiate a Phase 2 study following IND submission. --Phase 2 study in cancer...royalties for the fourth quarter increased 13...is about to enter Phase 2 clinical testing. In the fourth quarter of 2004, we evaluated...
- A.P. Pharma Reports 2005 Full Year and Fourth Quarter Results; APF530 Phase 3...
- Press release article from: Business Wire March 15, 2006 700+ words
...expense in the fourth quarter of 2005 was $3...055,000 in the fourth quarter of the prior year...the cost of the Phase 2 clinical study...preparations for the Phase 3 trial. General...expense in the fourth quarter of 2005 was $1...
- Phase Forward Reports Fourth Quarter and 2005 Results; Achieves 18% Revenue...
- Press release article from: Business Wire February 7, 2006 700+ words
...WALTHAM, Mass. -- Phase Forward (NASDAQ: PFWD...financial results for the fourth quarter and year ended December...of 2006, the use of Phase Forward's InForm product...pharmaceutical companies. --Phase Forward continued to gain traction in the fourth quarter with small and ...
- Pain Therapeutics Announces Fourth Quarter and Year End 2004 Financial Results;...
- Press release article from: PR Newswire January 26, 2005 700+ words
...data from our Phase III trials...million in the fourth quarter of 2004 from...expenses in the fourth quarter of 2004 included on-going Phase III trial...initiation of the Phase III trial...million in the fourth quarter of 2004 from...
- Icagen Reports Fourth Quarter and Full Year 2004 Financial Results and Reports...
- Press release article from: PR Newswire March 30, 2005 700+ words
...results of our Phase Ib study of ICA...Financials For the fourth quarter of 2004, net loss...889,000 in the fourth quarter of 2003 due primarily...of the research phase of the Company...million in the fourth quarter of 2004 from...